Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000649096 | SCV000770921 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2023-09-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001529127 | SCV001773779 | uncertain significance | not provided | 2020-11-25 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Ambry Genetics | RCV002386092 | SCV002671197 | uncertain significance | Cardiovascular phenotype | 2021-09-09 | criteria provided, single submitter | clinical testing | The p.R2467C variant (also known as c.7399C>T), located in coding exon 45 of the FLNC gene, results from a C to T substitution at nucleotide position 7399. The arginine at codon 2467 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Diagnostic Laboratory, |
RCV001529127 | SCV001742062 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001529127 | SCV001973353 | uncertain significance | not provided | no assertion criteria provided | clinical testing |